文献速递放疗物理与技术姑息放疗与转移瘤

低能X线电子术中放疗治疗原发与复发软组织肉瘤

Intraoperative radiotherapy with low energy x-rays for primary and recurrent soft-tissue sarcomas.
PubMed 文献 · Radiat Oncol · 2020-05-14

中位随访4.88年,5年估计总生存率94.7%,未见与eIORT相关的G3毒性,结论认为低能光子eIORT是软组织肉瘤的安全治疗选择,结局与电子线IORT或HDR近距离治疗的历史系列相似。

要点

  • 低能光子eIORT治疗软组织肉瘤未见G3毒性,安全性可接受。
  • 复发软组织肉瘤中位局部无进展生存12.5个月,5年估计65.5%。
  • 5年估计总生存率94.7%,原发灶仅1例在22个月后局部复发。

核心结论

  • 低能光子电子术中放疗是软组织肉瘤的安全治疗选择,结局与电子线IORT或HDR近距离治疗的历史系列相似。

主要发现

  • 中位随访4.88年(范围1.0-8.95年),25例(80.6%)为既往治疗后的复发软组织肉瘤。
  • 总体无进展生存中位11.0个月,5年估计42.6%;复发患者局部无进展生存中位12.5个月,5年估计65.5%。
  • 5年估计总生存率94.7%,原发灶仅1例在22个月后出现局部复发。
  • 未见与eIORT相关的G3毒性,2例出现G2急性神经病理性疼痛,6例出现晚期神经病理性疼痛(3例G1、3例G2),无伤口相关毒性。

关键数值与推荐

  • 切除状态R1占25.8%、R2占6.5%;肿瘤分布为四肢51.7%、腹盆腔35.5%、胸部9.7%、头颈部3.2%。

临床怎么用

  • 对于原发或复发软组织肉瘤,可考虑在手术中联合低能光子eIORT,需关注神经病理性疼痛等不良事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Soft tissue sarcomas (STS) treatment remains a therapeutic challenge. Intraoperative radiotherapy (IORT) resembles a safe and efficient for STS treatment. The first data on electronic-IORT (eIORT) using low-energy photons is herein presented. METHODS: Thirty-one patients with newly and recurrent STS were retrospectively assessed. EIORT was applied with low-energy photons during surgery. The dose was either prescribed to the applicator surface (spherical applicators) or 5 mm depth (flat applicators). Overall progression-free survival (O-PFS), local progression-free survival (L-PFS), overall survival (OS) and adverse events were evaluated. RESULTS: Median follow-up was 4.88 (1.0-8.95) years. Twenty-five patients (80.6%) had recurrent STS with prior treatment. The resection status was R1 in 25.8% and R2 in 6.5%. The distribution was 51.7% for extremities, 35.5% for abdomen and pelvis, 9.7% for thorax and 3.2% for head and neck tumors. The median O-PFS was 11.0 months, with 42.6% 5-year estimated O-PFS. The only local recurrence in the primary setting occurred after 22 months. Median L-PFS in recurrent STS was 12.5 months, with 65.5% 5-year estimated L-PFS. The 5-year OS estimated rate was 94.7% (3 events after 7 years). No G3 toxicity related to eIORT was observed. Two patients exhibited G2 acute neuropathic pain. Late neuropathic pain was seen in 6 patients being 3 graded as G1 and 3 as G2. No wound-related toxicity was found. CONCLUSION: Electronic IORT with low-energy photons is a safe treatment option for STS, yielding similar outcomes as historical series reporting IORT with electrons or HDR brachytherapy.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Sarria GR, Petrova V, Wenz F, et al. Intraoperative radiotherapy with low energy x-rays for primary and recurrent soft-tissue sarcomas. Radiat Oncol. 2020. PMID: 32410696. doi:10.1186/s13014-020-01559-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。